Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice  Paolo Angeli, Pere Gines  Journal of Hepatology  Volume 57, Issue 5, Pages 1135-1140 (November 2012) DOI: 10.1016/j.jhep.2012.06.024 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Dynamic behavior of the ratio of urinary excretion of γ-glutamyltranspeptidase to glomerular filtration rate in patients with type 1 HRS according to the response to pharmacological treatment. Data from Ref. [5]. B, baseline; D, day after the initiation of treatment; the area under the dotted line represents the normal range for this parameter in our laboratory. No response was defined by a decrease in pretreatment peak serum creatinine less than 50%. Journal of Hepatology 2012 57, 1135-1140DOI: (10.1016/j.jhep.2012.06.024) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2012 57, 1135-1140DOI: (10. 1016/j. jhep. 2012 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions